Exponent Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Exponent Technologies, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include EXPONENTHR. The owner is based in Dallas, TX.
4970 Landmark Place
Dallas, TX 75254
Showing of trademarks Trademarks
Trademark Classifications
Exponent Technologies, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Exponent Technologies, Inc. have?
Exponent Technologies, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 cancelled.
What trademark classes does Exponent Technologies, Inc. file in?
Exponent Technologies, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Exponent Technologies, Inc.'s most well-known trademarks?
Exponent Technologies, Inc.'s registered trademark portfolio includes well-known marks such as EXPONENTHR. These are among 7 currently registered trademarks in the portfolio.
What is Exponent Technologies, Inc.'s trademark registration success rate?
Exponent Technologies, Inc. has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.